Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SRINIVASA R KODALI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1255372058
CMS profile
148006
Location
LIVONIA, MI

General Payments · PY2018–2024

$5,612.79

  • Reported across 260 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$440.55

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $440.55 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $135.62 2
Alkermes, Inc. $111.85 2
ABBVIE INC. $50.34 3
Lundbeck LLC $48.21 2
Supernus Pharmaceuticals, Inc. $44.45 2
ITI, Inc. $26.64 1
Takeda Pharmaceuticals U.S.A., Inc. $23.44 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,685.63 92
PY2019 $1,771.77 89
PY2020 $322.06 14
PY2021 $344.69 15
PY2022 $705.52 24
PY2023 $342.57 13
PY2024 $440.55 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.90 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104091790 CMS
ABBVIE INC. $13.23 07/22/2024 Food and Beverage Undisputed 01/23/2026 1104091792 CMS
ABBVIE INC. $15.21 08/13/2024 Food and Beverage Undisputed 01/23/2026 1104091794 CMS
Alkermes, Inc. $26.94 02/28/2024 Food and Beverage Undisputed 01/23/2026 1120534094 CMS
Alkermes, Inc. $84.91 04/24/2024 Food and Beverage Undisputed 01/23/2026 1120534098 CMS
E.R. Squibb & Sons, L.L.C. $13.59 10/29/2024 Food and Beverage Undisputed 01/23/2026 1101723489 CMS
E.R. Squibb & Sons, L.L.C. $122.03 11/18/2024 Food and Beverage Undisputed 01/23/2026 1101723540 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.64 08/14/2024 Food and Beverage Undisputed 01/23/2026 1143258253 CMS
Lundbeck LLC $18.55 02/01/2024 Food and Beverage Undisputed 01/23/2026 1145934960 CMS
Lundbeck LLC $29.66 09/30/2024 Food and Beverage Undisputed 01/23/2026 1145934962 CMS
Supernus Pharmaceuticals, Inc. $20.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1147882496 CMS
Supernus Pharmaceuticals, Inc. $24.45 11/03/2024 Food and Beverage Undisputed 01/23/2026 1147779116 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.44 04/24/2024 Food and Beverage Undisputed 01/23/2026 1137604996 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.